共 138 条
[1]
Seliger SL(2003)Elevated risk of stroke among patients with end-stage renal disease Kidney Int 64 603-609
[2]
Gillen DL(2009)Chronic kidney disease and clinical outcome in patients with acute stroke Stroke 40 1296-1303
[3]
Longstreth WT(2012)Mechanisms of anemia in CKD J Am Soc Nephrol 23 1631-1634
[4]
Kestenbaum B(1989)Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial Ann Intern Med 111 992-1000
[5]
Stehman-Breen CO(2009)Predictors of hyporesponsiveness to erythropoiesis-stimulating agents in hemodialysis patients Am J Kidney Dis 53 823-834
[6]
Yahalom G(2015)Hyporesponsiveness to erythropoiesis-stimulating agent as a prognostic factor in Japanese hemodialysis patients: the Q-Cohort study J Nephrol 28 217-225
[7]
Schwartz R(2008)Factors that condition the response to erythropoietin in patients on hemodialysis and their relation to mortality Kidney Int 74 75-81
[8]
Schwammenthal Y(2009)A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease N Engl J Med 361 2019-2032
[9]
Merzeliak O(2010)Erythropoietic response and outcomes in kidney disease and type 2 diabetes N Engl J Med 363 1146-1155
[10]
Toashi M(2016)Association between serum phosphate levels and stroke risk in patients undergoing hemodialysis: the Q-Cohort Study Stroke 47 2189-2196